BrainStorm Shareholder Seeks Access to Board’s FDA Snub Records
A BrainStorm Cell Therapeutics Inc. stockholder requested a Delaware court order the biopharmaceutical company turn over board minutes and other documents tied to a stem-cell treatment that failed to get regulatory approval.